BIO-RAD LABORATORIES, INC. Deferred Income Tax Liabilities, Net
BIO-RAD LABORATORIES, INC. (BIO.B) had Deferred Income Tax Liabilities, Net of $982.20 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-04
- 2026-06-30: Deferred Income Tax Liabilities, Net $982.20M.
- 2026-03-31: Deferred Income Tax Liabilities, Net $881.80M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $1.06B.
- 2025-09-30: Deferred Income Tax Liabilities, Net $872.60M.
| Period end | Deferred Income Tax Liabilities, Net | Deferred Income Tax Liabilities, Net as first filed |
|---|---|---|
| 2026-06-30 | $982.20M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $881.80M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $1.06B 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $872.60M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $961.00M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $840.80M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $818.00M 10-K · filed 2026-02-13 | |
| 2024-09-30 | $1.08B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $878.46M 10-Q · filed 2024-08-02 | |
| 2024-03-31 | $1.54B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.48B 10-K · filed 2025-02-14 | $1.48B 10-K · filed 2024-02-16 |
| 2023-09-30 | $1.37B 10-Q · filed 2023-10-27 | |
| 2023-06-30 | $1.40B 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $1.77B 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $1.77B 10-K · filed 2024-02-16 | |
| 2022-09-30 | $1.48B 10-Q · filed 2022-10-28 | |
| 2022-06-30 | $1.61B 10-Q · filed 2022-07-29 | |
| 2022-03-31 | $2.00B 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $3.06B 10-K · filed 2023-02-17 | $3.06B 10-K · filed 2022-02-11 |
| 2021-09-30 | $3.57B 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $2.54B 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $2.31B 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $2.08B 10-K · filed 2022-02-11 | |
| 2020-09-30 | $1.84B 10-Q · filed 2020-10-30 | |
| 2020-06-30 | $1.46B 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $1.16B 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $997.79M 10-K · filed 2021-02-16 |